NasdaqCM - Delayed Quote USD
Cardio Diagnostics Holdings, Inc. (CDIO)
At close: 4:00 PM EDT
After hours: 6:32 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -0.1 | -0.11 | -0.45 | -0.25 |
| Low Estimate | -0.15 | -0.16 | -0.55 | -0.25 |
| High Estimate | -0.05 | -0.06 | -0.36 | -0.25 |
| Year Ago EPS | -0.16 | 0 | -0.66 | -0.45 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | 100k | 190k | 370k | 520k |
| Low Estimate | 10k | 20k | 60k | 520k |
| High Estimate | 200k | 350k | 670k | 520k |
| Year Ago Sales | 10k | 5k | 17k | 370k |
| Sales Growth (year/est) | 900.00% | 3,700.00% | 2,076.50% | 40.50% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.27 | -0.13 | -0.09 | -0.11 |
| EPS Actual | -0.16 | 0 | -0.2 | -0.06 |
| Difference | 0.11 | 0.13 | -0.11 | 0.05 |
| Surprise % | 40.70% | 100.00% | -122.20% | 45.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.11 | -0.45 | -0.25 |
| 7 Days Ago | -0.1 | -0.11 | -0.45 | -0.25 |
| 30 Days Ago | -0.1 | -0.11 | -0.45 | -0.25 |
| 60 Days Ago | -0.1 | -0.11 | -0.45 | -0.25 |
| 90 Days Ago | -0.11 | -0.12 | -0.5 | -0.37 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CDIO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 37.50% | -- | -- | 5.10% |
| Next Qtr. | -- | -- | -- | 11.80% |
| Current Year | 31.80% | -- | -- | 2.10% |
| Next Year | 44.40% | -- | -- | 12.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.68% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 8/27/2024 |
| Maintains | Benchmark: Speculative Buy to Speculative Buy | 6/6/2024 |
| Maintains | Benchmark: Speculative Buy to Speculative Buy | 4/19/2024 |
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 6/15/2023 |
| Initiated | Northland Capital Markets: Outperform | 5/22/2023 |
| Reiterates | Benchmark: Speculative Buy | 4/18/2023 |
Related Tickers
SPRC SciSparc Ltd.
0.2331
-5.89%
ADTX Aditxt, Inc.
0.5299
-4.52%
GRI GRI Bio, Inc.
1.1000
+25.28%
PXMD PaxMedica, Inc.
0.1005
+10.80%
HOTH Hoth Therapeutics, Inc.
0.8600
+1.18%
BNOX Bionomics Limited
0.1969
-1.25%
TPST Tempest Therapeutics, Inc.
0.9094
-0.62%
TCBP TC Biopharm (Holdings) Plc
1.3100
-0.76%
LIXT Lixte Biotechnology Holdings, Inc.
2.0200
-4.27%
ELAB Elevai Labs Inc.
0.0289
-51.02%